En Carta Diagnostics secured €1.5 million in pre-seed funding led by CentraleSupélec Venture to advance platform for early Lyme disease detection
May 22, 2024•over 1 year ago
Amount Raised
€1.5 Million
Round Type
seed
ParisHealth DiagnosticsBiotechnologyHealth CareInvestors
High Profile Business AngelsCentrale Supélec Venture
Description
En Carta Diagnostics, a startup specializing in rapid Point-of-Care molecular diagnostics, has announced the completion of a €1.5 million pre-seed funding round. This investment will be utilized to further the development of a prototype diagnostic kit for early Lyme disease detection and to facilitate scalability.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers